Drug name: Cyramza ®
INN: Ramucirumab
API type: Ramucirumab is a human IgG1 monoclonal antibody produced in murine (NS0) cells by recombinant DNA technology.
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies
ATC code: L01XC21
General function:
Short description:
Original license holder:
Marketing authorisation numbers: EU/1/14/957/001 - 003
Marketing authorisation holder: Eli Lilly Nederland B.V.; Papendorpseweg 83; 3528 BJ Utrecht; The Netherlands
Name of the manufacturer of the biological active substance: ImClone Systems LLC; 33 ImClone Drive, Branchburg; New Jersey; NJ 08876; UNITED STATES
Name and address of the manufacturer responsible for batch release: Lilly, S.A.; Avda de la Industria, 30; Alcobendas; 28108 Madrid; Spain
Max shelf life: 36 months
Storage conditions: 2°C – 8°C
List of excipients: Histidine, Histidine monohydrochloride, Sodium chloride, Glycine (E640), Polysorbate 80 (E433), Water for injections